Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions

Antoine N Saliba, Afif R Harb, Ali T Taher Department of Internal Medicine, Division of Hematology/Oncology, American University of Beirut, Beirut, Lebanon Abstract: Transfusional iron overload is a major target in the care of patients with transfusion-dependent thalassemia (TDT) and other refracto...

Full description

Bibliographic Details
Main Authors:	Saliba AN, Harb AR, Taher AT
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-06-01
Series:	Journal of Blood Medicine
Online Access:	http://www.dovepress.com/iron-chelation-therapy-in-transfusion-dependent-thalassemia-patients-c-peer-reviewed-article-JBM

Similar Items

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
by: Rayan Bou-Fakhredin, et al.
Published: (2017-12-01)

Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review
by: M Hashemieh
Published: (2020-08-01)

Non-transfusion dependent thalassemia: translating evidence to guidelines
by: Afif R. Harb, et al.
Published: (2014-12-01)

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion
by: Monica Pinheiro de Almeida Verissimo, et al.
Published: (2013-01-01)

Thalassemia Major: Transplantation or Transfusion and Chelation
by: Said Y. Mohamed
Published: (2017-12-01)

IRON CHELATION THERAPY IN THALASSEMIA SYNDROMES
by: Paolo Cianciulli
Published: (2009-06-01)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes
by: Kontoghiorghe CN, et al.
Published: (2016-01-01)

Iron overload in non-transfusion-dependent thalassemia
by: Khaled M. Musallam
Published: (2013-03-01)

Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
by: Mohamed Abdel Malik Hassan, et al.
Published: (2016-05-01)

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
by: Joseph Sleiman, et al.
Published: (2018-01-01)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
by: Taher AT, et al.
Published: (2016-12-01)

Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: Our experience
by: Jethani Jitendra, et al.
Published: (2010-01-01)

Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives
by: Bayanzay K, et al.
Published: (2016-08-01)

Quality of life: Transfusion dependent thalassemia vs non-transfusion dependent thalassemia
by: Mehran Karimi, et al.
Published: (2018-04-01)

Understanding Iron Metabolism: Lessons from Transfusion-dependent Thalassemia
by: Murtadha Al-Khabori, et al.
Published: (2018-01-01)

Reducing the iron burden and improving survival in transfusion-dependent thalassemia patients: current perspectives [Corrigendum]
by: Bayanzay K, et al.
Published: (2016-10-01)

Osteoporosis in Transfusion Dependent Thalassemia
by: Mozhgan Hashemieh
Published: (2019-11-01)

Evaluation of cardiac complications in transfusion-dependent thalassemia (TDT) and non-transfusion dependent thalassemia (NTDT) beta thalassemia patients
by: Marah Sudad Nameq, et al.
Published: (2020-01-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Mohammad Ali Mashhadi, et al.
Published: (2011-06-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Ebrahim miri moghaddam, et al.
Published: (2011-04-01)

Erythropoiesis and Iron Homeostasis in Non-Transfusion-Dependent Thalassemia Patients with Extramedullary Hematopoiesis
by: Yumei Huang, et al.
Published: (2019-01-01)

On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
by: Carpenter JP, et al.
Published: (2011-09-01)

Side effect of deferiprone as iron chelator in patient with thalassemia
by: Mikhael Yosia, et al.
Published: (2018-01-01)

Hepcidin gene polymorphisms and iron overload in β-thalassemia major patients refractory to iron chelating therapy
by: Parinaz Zarghamian, et al.
Published: (2020-04-01)

Combination iron chelation therapy with deferiprone and deferasirox in iron-overloaded patients with transfusiondependent β-thalassemia major
by: Hossein Karami, et al.
Published: (2017-01-01)

Time to Start Delivering Iron Chelation Therapy in Newly Diagnosed Severe β-Thalassemia
by: Susi Susanah, et al.
Published: (2020-01-01)

Correlations between Iron Load and CD4 in Adult Transfusion-Dependent Beta Thalassemia
by: Tubagus Djumhana Atmakusuma, et al.
Published: (2021-01-01)

Quality of life in transfusion-dependent thalassemia patients
by: Rizqallah A. Alzahrani, et al.
Published: (2017-10-01)

Alloimmunization among transfusion-dependent thalassemia patients
by: Sadeghian Mohammad, et al.
Published: (2009-01-01)

Physical growth in children with transfusion-dependent thalassemia
by: Harish K Pemde, et al.
Published: (2011-02-01)

Iron overload and chelation therapy in hemoglobinopathies
by: Rayan Bou-Fakhredin, et al.
Published: (2018-04-01)

Rapid Iron Loading in Heart and Liver in a Patient with Transfusion Dependent Thalassaemia after Brief Poor Compliance with Iron Chelation Therapy
by: Shahina Daar, et al.
Published: (2010-12-01)

Current strategies and future directions for the prevention of transfusion-transmitted cytomegalovirus
by: Harmon CM, et al.
Published: (2017-04-01)

Therapeutic Value of Silymarin as Iron Chelator in Children with Beta Thalassemia with Iron Overload
by: adel abd elhaleim hagag
Published: (2014-08-01)

The crisis of iron in transfusion medicine : improved iron chelation therapy and its implications for clinical practice in the Maldives
by: Mustafa, Ibrahim
Published: (2011)

The crisis of iron in transfusion medicine : improved iron chelation therapy and its implications for clinical practice in the Maldives
by: Mustafa, Ibrahim
Published: (2011)

The crisis of iron in transfusion medicine : improved iron chelation therapy and its implications for clinical practice in the Maldives
by: Mustafa, Ibrahim
Published: (2011)

"Evaluation Of compliance To Iron Chelation Therapy With Defe-Roxamine In Patients With Major Thalassemia In Iran In 2004 "
by: M. Izadyar, et al.
Published: (2006-06-01)

Heart Rate Variability for Early Detection of Cardiac Iron Deposition in Patients with Transfusion-Dependent Thalassemia.
by: Suchaya Silvilairat, et al.
Published: (2016-01-01)

Effects of Vitamin E on Transfusion Requirements in TransfusionDependent Beta-Thalassemia Patients
by: Duangdee Trangsuwan, et al.
Published: (2018-08-01)